1 - 1 out of 1Page size: 10
  1. 2021

  2. Kinase inhibitors developed for treatment of hematologic malignancies: Implications for immune modulation in COVID-19

    Jacobs, C. F., Eldering, E. & Kater, A. P., 9 Feb 2021, In: Blood advances. 5, 3, p. 913-924 12 p.

    Research output: Contribution to journal › Article › Academic › peer-review

ID: 11376498